On the other hand, in lung cancer with mutations in PARK2 (encoding Parkin), Parkin fails to translocate onto mitochondria and is unable to recruit downstream mitophagic regulators [45] (Figure 1F, Table S1). Here, PRKN is linked to lung carcinoma.